Apogee Therapeutics (APGE) Common Equity (2022 - 2026)
Apogee Therapeutics (APGE) posted Common Equity of $1.19 billion for Q2 2026, up 92.9% from $619.4 million a year earlier but down 4.9% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Common Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, Apogee Therapeutics' Common Equity came in at $903.88 million, up 26.1% from FY2024.
- In prior years, Apogee Therapeutics' Common Equity was $716.79 million in FY2024 (+88.7%), $379.91 million in FY2023 and -$35.39 million in FY2022.
- Quarterly Common Equity has run from a low of -$64.42 million in Q2 2023 to a high of $1.26 billion in Q1 2026 over five years.
- On a year-over-year basis, Common Equity has increased in each of the last three quarters, with growth averaging 39.7% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q2 2026, with growth of 92.9%; the weakest was Q3 2025, with a decline of 20.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $1.26 billion (Q1 2026), $903.88 million (Q4 2025) and $586.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 1.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Bn |
| Mar 31, 2026 | 1.26 Bn |
| Dec 31, 2025 | 903.88 Mn |
| Sep 30, 2025 | 586.34 Mn |
| Jun 30, 2025 | 619.40 Mn |
| Mar 31, 2025 | 673.36 Mn |
| Dec 31, 2024 | 716.79 Mn |
| Sep 30, 2024 | 734.40 Mn |
| Jun 30, 2024 | 773.64 Mn |
| Mar 31, 2024 | 801.48 Mn |
| Dec 31, 2023 | 379.91 Mn |
| Sep 30, 2023 | 409.24 Mn |
| Jun 30, 2023 | -64.42 Mn |
| Mar 31, 2023 | -46.64 Mn |
| Dec 31, 2022 | -35.39 Mn |
| Sep 30, 2022 | -24.09 Mn |
| Jun 30, 2022 | -4.43 Mn |
API Access
Apogee Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();